Exercise, Irisin, and Brain Health Exercise has long been...see more associated with better brain health, and now research indicates it may even have the potential to slow the progression of Parkinson’s disease (PD). While PD symptom management options are plentiful, there have been no proven methods […]

Read More

Progress is underway! The inaugural Advisory Council on Parkinson’s Research,...see more Care, and Services (ACPRCS) meeting took place on June 29, 2026 — an important step forward in the national effort to prevent, diagnose, treat, and ultimately cure Parkinson’s disease and related disorders.   During this first meeting, Parkinson’s disease Congressional champions, […]

Read More

APDA applauds Vermont lawmakers for passing first-in-the-nation legislation to...see more phase out and ultimately ban paraquat, a highly toxic herbicide that has been linked in numerous scientific studies to an increased risk of Parkinson’s disease. The bill is headed to the governor’s desk. For the Parkinson’s […]

Read More

Yesterday, the House voted 280-142 to an amendment in the Farm Bill,...see more ensuring states continue to have the right to decide how best to protect their residents from toxic herbicides including one that has been linked to Parkinson’s disease (PD). Studies have shown that people exposed to paraquat […]

Read More

On March 20, 2026, the U.S. Food...see more and Drug Administration (FDA) issued a safety warning that requires products containing carbidopa/levodopa to carry new labeling which warns about the potential for Vitamin B6 (pyridoxine) deficiency. The warning guides physicians and other health care professionals […]

Read More

APDA Applauds Seating of the National Advisory Council on Parkinson’s Research, Care, and Services   APDA Advocates Secure Important Spots on Council with...see more Appointment of Cathi Ann Thomas, MS, RN, CNRN and David G. Standaert, MD, PhD                                           The U.S. Department of Health and Human Services has announced the appointment of members to the National Advisory Council on Parkinson’s Research, Care, and Services. Established under […]

Read More

A newly released report, co-sponsored by the...see more American Parkinson Disease Association, has shown that Parkinson’s disease (PD) and atypical Parkinsonism are placing an $82.2 billion annual economic burden on the United States as of 2024—highlighting the growing financial strain of these neurological conditions. […]

Read More

A major milestone has been reached as Japan has approved the world’s first stem-cell-based therapy for Parkinson’s disease (PD)....see more The innovation was developed by Sumitomo Pharma in collaboration with Dr. Jun Takahashi at Kyoto University. This treatment represents a new approach that could potentially restore lost brain cells of PD. How it Works Dr. Takahashi […]

Read More